Browsing: GLP-1
Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in five large employers…
At least two in five U.S. adults — or more than 57 million people – under the age of 65…
A whopping 1 in 8 U.S. adults have taken GLP-1 drugs like Wegovy and Ozempic for weight loss and related…
Topline Popular diabetes and weight loss drugs like Ozempic and Wegovy, known as GLP-1 medications, were not found to cause…
Amid increased concern about the costs of using glucagon-like peptide 1 agonists to treat obesity, some insurers are imposing further…
The weight loss drug Wegovy secured a supplemental cardiovascular indication from the Food and Drug Administration last month. This allows…
Topline Ozempic maker Novo Nordisk on Thursday teased a potential successor to its blockbuster weight loss drug Wegovy, the latest…
In the February 4, 1735 issue of the Pennsylvania Gazette, Benjamin Franklin wrote that “an ounce of prevention is worth…
Millions of people inject the new “miraculous” weight loss drugs targeting Glucagon-like peptide-1 (GLP-1) such as Wegovy, Ozempic, and Mounjaro.…